China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) EBIT per Share : $0.23 (TTM As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is China Shineway Pharmaceutical Group EBIT per Share?

China Shineway Pharmaceutical Group's EBIT per Share for the six months ended in Dec. 2023 was $0.11. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.23.

During the past 12 months, the average EBIT per Share Growth Rate of China Shineway Pharmaceutical Group was 32.30% per year. During the past 3 years, the average EBIT per Share Growth Rate was 28.00% per year. During the past 5 years, the average EBIT per Share Growth Rate was 16.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for China Shineway Pharmaceutical Group's EBIT per Share or its related term are showing as below:

CSWYF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.8 Med: 4.2 Max: 43.7
Current: 28

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of China Shineway Pharmaceutical Group was 43.70% per year. The lowest was -19.80% per year. And the median was 4.20% per year.

CSWYF's 3-Year EBIT Growth Rate is ranked better than
75.64% of 858 companies
in the Drug Manufacturers industry
Industry Median: 7.7 vs CSWYF: 28.00

China Shineway Pharmaceutical Group's EBIT for the six months ended in Dec. 2023 was $80.0 Mil.

China Shineway Pharmaceutical Group EBIT per Share Historical Data

The historical data trend for China Shineway Pharmaceutical Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group EBIT per Share Chart

China Shineway Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.12

0.08

0.15

0.17

0.23

China Shineway Pharmaceutical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.07	0.08	0.10	0.12	0.11

China Shineway Pharmaceutical Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

China Shineway Pharmaceutical Group's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	174.083	/	755.400
=	0.23

China Shineway Pharmaceutical Group's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	80.044	/	755.400
=	0.11

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.23

China Shineway Pharmaceutical Group (OTCPK:CSWYF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

China Shineway Pharmaceutical Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (OTCPK:CSWYF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

02877:Hong Kong C1S:Germany

Address

Luan Cheng, Hebei Province, Shijiazhuang, CHN

Website

http://www.shineway.com.hk

China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. Principally, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.

China Shineway Pharmaceutical Group (China Shineway Pharmaceutical Group) Headlines

From GuruFocus

China Shineway Pharmaceutical Group Ltd (CSWYF): A Deep Dive into its Dividend Performance

By GuruFocus Research • 09-12-2023